Schultze and Clever Leaves announced today that they have amended their definitive merger agreement. Under the revised terms, the expected enterprise value has been reduced to $206 million from $255 million and the minimum cash condition for the SPAC has been reduced to $26 million from $60 million. The deal is expected to close by year’s end.
Clever is a pharmaceutical-grade multi-national cannabis operator.
If approved, Clever will trade on the NASDAQ under the symbol “CLVR”. Read more.
